Xcout Intel
Calypso Biotech competitors & alternatives
The 12 closest competitors and alternatives to Calypso Biotech among biotechnology companies — ranked by similarity to what Calypso Biotech actually does, not by market-cap band.
Subscribe to see Calypso Biotech’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Calypso Biotech
Calypso Biotech is a spin-off pharmaceutical company focusing on developing therapeutics for conditions such as celiac disease.
Calypso Biotech at a glance
Calypso Biotech is a biotechnology company. It has raised at least $32M across the 2 funding rounds on record. Its most recent funding round, Series A, raised $9.4M in September 2021.
Calypso Biotech funding rounds
At least $32M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $9.4M | 1 named | |
| Series A | $22.6M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Calypso Biotech competitors
Ranked by semantic similarity — how close each company is to Calypso Biotech by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Giiant Pharma is a Montreal-based biotechnology company founded by former Merck Frosst scientists with the aim of developing orally-administered, gut-restricted therapeutics.
Biotech
Calliditas Therapeutics AB is a commercial-stage biopharma company based in Stockholm, Sweden. It focuses on developing and commercializing pharmaceutical products.
Similar biotechnology company
Canopy Immuno-Therapeutics is a pre-clinical stage biotechnology company based in Haifa, Israel, focused on developing non-immunosuppressive biologics, including Antigen-Drug Conjugates, for antibody-mediated autoimmune conditions.
Similar biotechnology company
Applied Molecular Transport was a United States biotechnology company that developed oral biologic medicines using a proprietary epithelial drug-delivery platform. Its programs targeted gastrointestinal and autoimmune diseases, serving patients with conditions such as inflammatory bowel disease.
Biotech
Palisade Bio, Inc. is a clinical-stage biopharmaceutical firm dedicated to identifying, advancing, and bringing to market orally administered treatments for significant conditions stemming from a compromised gastrointestinal mucosal barrier. The company's primary therapeutic candidate, LB1148, is an oral liquid formulation designed to inhibit digestive enzymes. Its goal is to safeguard gut integrity when the intestine experiences stress due to factors such as diminished blood supply, infections, or surgical procedures. Established in 2005, the company maintains its headquarters in Carlsbad, California.
Similar biotechnology company
Meritage Pharma, Inc. is a private pharmaceutical company focused on developing oral budesonide suspension as a treatment for eosinophilic esophagitis.
Similar biotechnology company
SpliSense is an Israeli biotechnology company developing antisense oligonucleotide therapies that correct disease-causing RNA splicing defects. Its programs are aimed at patients with genetic diseases, including specific mutations associated with cystic fibrosis.
Similar biotechnology company
Exeliom Biosciences is a clinical-stage biopharmaceutical company headquartered in France that develops novel therapeutic approaches harnessing microbiome-host interactions.
Similar biotechnology company
Cellics Therapeutics, Inc. is a privately held biotechnology company headquartered in San Diego, California, developing novel therapeutic products.
Similar biotechnology company
Evommune is a clinical-stage biopharmaceutical company headquartered in Palo Alto, California, developing new treatments for immune-mediated chronic inflammatory diseases.
Biotech
ClostraBio, Inc. is a Chicago-based biotechnology research company pioneering microbiome-based solutions, next-generation probiotics for gut health, and advanced metabolite delivery solutions for inflammatory bowel disease.
Similar biotechnology company
Biora Therapeutics is a U.S. biotechnology company developing ingestible, device-based platforms for delivering biologic medicines to targeted areas of the gastrointestinal tract and into systemic circulation. Its technologies are intended for use by pharmaceutical and biotechnology companies developing oral or targeted biologic therapies.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Calypso Biotech and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Calypso Biotechand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →